Literature DB >> 23314702

Breaking through an epigenetic wall: re-activation of Oct4 by KRAB-containing designer zinc finger transcription factors.

Karla Juárez-Moreno1, Rafaela Erices, Adriana S Beltran, Sabine Stolzenburg, Mauricio Cuello-Fredes, Gareth I Owen, Haili Qian, Pilar Blancafort.   

Abstract

The gene Oct4 encodes a transcription factor critical for the maintenance of pluripotency and self-renewal in embryonic stem cells. In addition, improper re-activation of Oct4 contributes to oncogenic processes. Herein, we describe a novel designer zinc finger protein (ZFP) capable of upregulating the endogenous Oct4 promoter in a panel of breast and ovarian cell lines carrying a silenced gene. In some ovarian tumor lines, the ZFP triggered a strong reactivation of Oct4, with levels of expression comparable with exogenous Oct4 cDNA delivery. Surprisingly, the reactivation of Oct4 required a KRAB domain for effective upregulation of the endogenous gene. While KRAB-containing ZFPs are traditionally described as transcriptional repressors, our results suggest that these proteins could, in certain genomic contexts, function as potent activators and, thus, outline an emerging novel function of KRAB-ZFPs. In addition, we document a novel ZFP that could be used for the epigenetic reprograming of cancer cells.

Entities:  

Keywords:  DNA methylation; KRAB domain; Oct4; Zinc Finger Proteins; artificial transcription factors; breast cancer; epigenetics; serous epithelial ovarian cancer

Mesh:

Substances:

Year:  2013        PMID: 23314702      PMCID: PMC3592902          DOI: 10.4161/epi.23503

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  65 in total

1.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

Review 2.  Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells.

Authors:  Bo Feng; Jia-Hui Ng; Jian-Chien Dominic Heng; Huck-Hui Ng
Journal:  Cell Stem Cell       Date:  2009-04-03       Impact factor: 24.633

3.  Zfp206, Oct4, and Sox2 are integrated components of a transcriptional regulatory network in embryonic stem cells.

Authors:  Hong-bing Yu; Galih Kunarso; Felicia Huimei Hong; Lawrence W Stanton
Journal:  J Biol Chem       Date:  2009-09-09       Impact factor: 5.157

4.  Prediction and testing of novel transcriptional networks regulating embryonic stem cell self-renewal and commitment.

Authors:  Emily Walker; Minako Ohishi; Ryan E Davey; Wen Zhang; Paul A Cassar; Tetsuya S Tanaka; Sandy D Der; Quaid Morris; Timothy R Hughes; Peter W Zandstra; William L Stanford
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

5.  Epigenetic reprogramming of cancer cells via targeted DNA methylation.

Authors:  Ashley G Rivenbark; Sabine Stolzenburg; Adriana S Beltran; Xinni Yuan; Marianne G Rots; Brian D Strahl; Pilar Blancafort
Journal:  Epigenetics       Date:  2012-04-01       Impact factor: 4.528

6.  CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

Authors:  M-Q Gao; Y-P Choi; S Kang; J H Youn; N-H Cho
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

7.  Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).

Authors:  Adriana S Beltran; Pilar Blancafort
Journal:  Epigenetics       Date:  2011-02-01       Impact factor: 4.528

8.  Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.

Authors:  Claudia A Doege; Keiichi Inoue; Toru Yamashita; David B Rhee; Skylar Travis; Ryousuke Fujita; Paolo Guarnieri; Govind Bhagat; William B Vanti; Alan Shih; Ross L Levine; Sara Nik; Emily I Chen; Asa Abeliovich
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

9.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

10.  Suppression of breast tumor growth and metastasis by an engineered transcription factor.

Authors:  Adriana S Beltran; Angela Russo; Haydee Lara; Cheng Fan; Paul M Lizardi; Pilar Blancafort
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

View more
  11 in total

1.  Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion.

Authors:  Monique G P van der Wijst; Christian Huisman; Archibold Mposhi; Gerard Roelfes; Marianne G Rots
Journal:  Mol Oncol       Date:  2015-03-19       Impact factor: 6.603

2.  Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency.

Authors:  Ritu Kushwaha; Nirmala Jagadish; Manjunath Kustagi; Mark J Tomishima; Geetu Mendiratta; Mukesh Bansal; Hyunjae R Kim; Pavel Sumazin; Mariano J Alvarez; Celine Lefebvre; Patricia Villagrasa-Gonzalez; Agnes Viale; James E Korkola; Jane Houldsworth; Darren R Feldman; George J Bosl; Andrea Califano; R S K Chaganti
Journal:  Stem Cells       Date:  2015-02       Impact factor: 6.277

Review 3.  Epigenome engineering in cancer: fairytale or a realistic path to the clinic?

Authors:  Fahimeh Falahi; Agustin Sgro; Pilar Blancafort
Journal:  Front Oncol       Date:  2015-02-06       Impact factor: 6.244

4.  Modulation of Estrogen Response Element-Driven Gene Expressions and Cellular Proliferation with Polar Directions by Designer Transcription Regulators.

Authors:  Mesut Muyan; Gizem Güpür; Pelin Yaşar; Gamze Ayaz; Sırma Damla User; Hasan Hüseyin Kazan; Yanfang Huang
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

Review 5.  Reprogramming cells with synthetic proteins.

Authors:  Xiaoxiao Yang; Vikas Malik; Ralf Jauch
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

6.  Reprogramming to pluripotency using designer TALE transcription factors targeting enhancers.

Authors:  Xuefei Gao; Jian Yang; Jason C H Tsang; Jolene Ooi; Donghai Wu; Pentao Liu
Journal:  Stem Cell Reports       Date:  2013-07-11       Impact factor: 7.765

7.  Engineered zinc-finger transcription factors activate OCT4 (POU5F1), SOX2, KLF4, c-MYC (MYC) and miR302/367.

Authors:  Qingzhou Ji; Ashley L Fischer; Clyde R Brown; Erik R Eastlund; Tamar Dvash; Bonan Zhong; Mark A Gerber; Ian Lyons; Scott W Knight; Carol A Kreader
Journal:  Nucleic Acids Res       Date:  2014-05-03       Impact factor: 16.971

8.  Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation.

Authors:  Matthew R Grimmer; Sabine Stolzenburg; Ethan Ford; Ryan Lister; Pilar Blancafort; Peggy J Farnham
Journal:  Nucleic Acids Res       Date:  2014-08-13       Impact factor: 16.971

Review 9.  Genome-editing tools for stem cell biology.

Authors:  E A Vasileva; O U Shuvalov; A V Garabadgiu; G Melino; N A Barlev
Journal:  Cell Death Dis       Date:  2015-07-23       Impact factor: 8.469

Review 10.  Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.

Authors:  Mariana Brütt Pacheco; Vânia Camilo; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2021-06-15       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.